Eur Radiol: Please note that patients with sarcopenia after pancreatic cancer surgery may be related to a poor prognosis!

Pancreatic cancer is the seventh leading cause of cancer death in the world.

Pancreatic cancer is the seventh leading cause of cancer death in the world.

Sarcopenia is a progressive and systemic skeletal muscle disease that is associated with an increased likelihood of adverse consequences including falls, fractures, physical disability, and mortality.

Recently, a study published in the journal European Radiology used CT-based preoperative body composition analysis to quantitatively assess the muscle mass and quantity of patients with pancreatic cancer, and evaluated its relationship with pancreaticoduodenectomy (PD) for pancreatic cancer.

This study retrospectively included 116 patients (68 males and 48 females, with an average age of 66.

This study retrospectively included 116 patients (68 males and 48 females, with an average age of 66.

The 3-year DFS and OS rates were 8% and 25%, respectively.

Table 1 Univariate Cox proportional hazards model for assessing the impact of variables related to survival.

Table 1 Univariate Cox proportional hazards model for assessing the impact of variables related to survival.

Table 2 Multivariate Cox proportional hazards model for overall survival after pancreatic cancer resection.

Table 2 Multivariate Cox proportional hazards model for overall survival after pancreatic cancer resection.

    Preoperative sarcopenia assessed by CT is a poor prognostic factor for OS after PD in patients with pancreatic cancer.

Original source: Original source:

Yan-Chih Peng,Chien-Hui Wu,Yu-Wen Tien,et al.

Yan-Chih Peng,Chien-Hui Wu,Yu-Wen Tien,et al.
Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
DOI: 10.
1007/s00330-020-07294-7 10.
1007/s00330-020- 07294-7 Leave a message here